Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Clinica Baviera ( (ES:CBAV) ) has issued an update.
Aier Eye International (Europe), S.L.U. and Vito Gestión Patrimonial, S.L. are exploring the sale of up to 8% of Clínica Baviera’s share capital through an accelerated bookbuilt offering, targeting qualified investors. Alantra Equities is coordinating the operation, which will not provide proceeds to the company, and has agreements in place to restrict further share sales by the sellers for a specified period post-operation.
More about Clinica Baviera
YTD Price Performance: 11.32%
Average Trading Volume: 14
Technical Sentiment Signal: Strong Sell
Current Market Cap: €580.4M
For a thorough assessment of CBAV stock, go to TipRanks’ Stock Analysis page.